New facilities launched at Aayush Hospitals
The event was attended by prominent healthcare experts including Dr Kodur Gopalakrishna, Aayush Hospitals Managing Director, Dr Yarlagadda Ramesh Babu, Chairman, Aayush Hospitals Management Committee, Dr PSS Chowdary, Vice-Chairman, Management Committee, Meda Jayalakshmi, Chief Administrative Officer, critical care specialists, hospital administrative representatives, biomedical experts, and IT professionals. This collaboration between Aayush Hospitals, DocBox, and Care fluence marks a new milestone
in building the digital andAl future of Indian healthcare, the statement said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fashion Value Chain
a day ago
- Fashion Value Chain
Solo-Dex and Polymedicure Partner to Bring Opioid-Free Acute Pain Management to India and Major Asian Markets
Solo-Dex, Inc., a U.S.-based medical device innovator, and Polymedicure Ltd. (Polymed), Indias leading manufacturer of high-quality medical devices, today announced a strategic manufacturing and supply partnership to bring Solo-Dexs patented, opioid-free regional anesthesia solutions to hospitals across India for the first time. Under this agreement, Polymed will manufacture Solo-Dexs flagship product, the Fascile Continuous Peripheral Nerve Block system, in accordance with Solo-Dexs strict quality standards, for distribution across India and key global markets. The product is already approved for clinical use in the United States and Europe and is now set to support Indias expanding Enhanced Recovery After Surgery (ERAS) programs and the growth of outpatient surgical care. 'This is a game-changer for pain management in India,' said Steven Eror, CEO of Solo-Dex. 'Polymeds scale, precision, and strong regulatory framework make them the ideal manufacturing partner. Together, well deliver a transformative technology that goes far beyond suppressing pain-it blocks acute pain completely.' First-of-its-kind in India: Faster, Safer, Non-Opioid Pain Control Solo-Dexs patented device installs in under two minutes and enables continuous, localized pain relief without opioids. Unlike conventional methods that may require IV sedation and can result in patient delirium, Solo-Dex minimizes systemic drug exposure, and eliminates the need for oral opioids thereby improving patient safety, reducing recovery time, and decreasing demand on hospital resources. The technology is designed to seamlessly integrate with ERAS protocols, helping hospitals manage post-operative pain more efficiently. As Indias healthcare system increasingly embraces day surgery and outpatient models, Solo-Dex offers a solution that enhances patient throughput and satisfaction without compromising clinical outcomes. 'We are excited to be part of this international collaboration,' said Himanshu Baid, Managing Director of Polymed. 'This partnership not only brings cutting-edge pain management to Indian clinicians and patients, but also aligns with our commitment to making world-class healthcare more accessible.' Designed for Global Impact Manufacturing will take place in Polymeds ISO 13485-certified, FDA-auditable facilities, with initial orders for 100,000 units. In addition to serving India, the partnership aims to fulfill international demand across Asia, Africa, Latin America, and select European markets, with Solo-Dex overseeing global regulatory compliance and branding. 'Thanks to this agreement, Solo-Dex now has the scalable, cost-effective production capacity to meet global demand while maintaining the clinical precision and quality our technology requires,' said Eror. 'Were especially proud to collaborate with Polymed to address the worldwide need for safer, opioid-free surgical recovery.' The Solo-Dex and Polymed partnership is already engaging with leading hospital systems across India, with commercial availability expected to begin in Q4 2025. About Solo-Dex, Inc. Solo-Dex is a U.S.-based medical device company focused on opioid-free acute pain management. Its patented continuous peripheral nerve block systems enable anesthesiologists to deliver localized, long-lasting anesthesia for post-surgical recovery. Solo-Dex technology is approved for clinical use in the U.S. and EU. About Polymedicure Limited Polymed is one of Indias most trusted names in medical devices, with a portfolio of more than 125 FDA-approved and CE-marked products. With a global presence in over 100 countries, Polymed operates high-end manufacturing facilities and is committed to delivering innovative, high-quality healthcare solutions at scale.
Hans India
a day ago
- Hans India
New facilities launched at Aayush Hospitals
Vijayawada: Aayush Hospitals, Vijayawada, a 200-bed tertiary care facility accredited with NABH/NABL standards, has taken two significant steps forward in advancing digital health, patient safety and service quality, according to a press release. Launch of DocBox -- the Clinician Assistant in Critical Care—is state-of-the-art system that directly connects ICU biomedical devices to the hospital's digital records. The ABDM-Compliant, AI-Ready Healthcare Model captures bedside data, while Care fluence's ONC-certified FHIR platform integrates information from LIS, RIS, PACS, DMS, and biomedical devices into a single unified clinical view. Contribution to India's AI Mission supports the national vision by structuring and standardising clinical data for effective AI deployment. The event was attended by prominent healthcare experts including Dr Kodur Gopalakrishna, Aayush Hospitals Managing Director, Dr Yarlagadda Ramesh Babu, Chairman, Aayush Hospitals Management Committee, Dr PSS Chowdary, Vice-Chairman, Management Committee, Meda Jayalakshmi, Chief Administrative Officer, critical care specialists, hospital administrative representatives, biomedical experts, and IT professionals. This collaboration between Aayush Hospitals, DocBox, and Care fluence marks a new milestone in building the digital andAl future of Indian healthcare, the statement said.
The Hindu
3 days ago
- The Hindu
Kerala has set a model for the country in Ayurveda treatment, says Health Minister
Kerala's initiatives to ensure quality in Ayurveda have made it a model for the rest of the country, Health Minister Veena George has said. She was inaugurating a newly constructed women's hostel building and open-air stage at Government Ayurveda College, Pariyaram, Kannur on Monday (August 11, 2025). The Minister noted that Kerala was the only State with around 250 NABH-accredited AYUSH institutions. This was achieved by introducing an accreditation system in Ayurveda sector. 'We are moving forward with focussed efforts to ensure quality of Ayurveda medicines and to give special consideration to the growth of this sector,' she said. Research centre Ms. George said that work on an international Ayurveda research centre at Kalayad in Kannur was progressing. The centre was expected to enhance research and innovation in traditional medicine while strengthening the State's position as a global hub for Ayurveda, she said. The new women's hostel building, completed at a cost of ₹4 crore, has 19 rooms each on the first and second floors, with study halls and toilets blocks on both sides. The open-air stage, built at ₹10 lakh, is intended to support cultural and academic activities on the campus. M. VIjin, MLA, presided over the function. Other people's representatives, hospital authorities and officials were present.
